Skip to main content
Clinical Trials/NCT00708643
NCT00708643
Completed
Not Applicable

Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population

Johnson & Johnson Vision Care, Inc.1 site in 1 country80 target enrollmentJune 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Refractive Error
Sponsor
Johnson & Johnson Vision Care, Inc.
Enrollment
80
Locations
1
Primary Endpoint
Upper Lid Margin Staining
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study seeks to evaluate the clinical and subjective performance of a new daily disposable soft contact lens.

Registry
clinicaltrials.gov
Start Date
June 2008
End Date
September 2008
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • They are of legal age (17 years) and capacity to volunteer.
  • They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They would be expected to attain at least 6/9 (20/30) in each eye with the study lenses.
  • They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.
  • They have a maximum of 1.00D of refractive astigmatism (i.e. ≤ 1.00 DC).
  • They have successfully worn contact lenses within six months of starting the study.

Exclusion Criteria

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
  • They are pregnant or lactating.
  • They have grade 2 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
  • They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease (e.g. HIV).
  • They have diabetes.

Outcomes

Primary Outcomes

Upper Lid Margin Staining

Time Frame: At 2 weeks and 4 weeks.

Measures the trauma to tissue that lines the margin of the inside of the upper eyelid on a 0 to 3 scale, with 0=none to 3=severe. The analysis is the average grade over all time frames.

Limbal Hyperemia

Time Frame: At 2 weeks and 4 weeks

Measures the redness of the limbal region of the eye on a scale of 0 to 100 grade with 0=none and 100=severe. The analysis is the average grade over all time frames.

Lens Comfort

Time Frame: At 3,7,10,13,17,21,24, and 27 days

Rating of lens comfort by rating agreement to the following statement: "The lenses I am wearing are comfortable." Rating using the following scale: 1=strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree. The rating is averaged over all time frames.

Secondary Outcomes

  • Corneal Staining(At 2 weeks and 4 weeks.)
  • Tarsal Hyperemia(At 2 weeks and 4 weeks.)
  • Tarsal Roughness(At 2 weeks and 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials